Aphria Inc. APHA

Aphria # 1 in Canada with A1 & DD Just Getting Started

[Savage97]

Positive EBITDA gives a sense of how well a company is handling its operating expenses, Aphria reported EBITDA of CA$8.6 million, a stunning 49% increase from CA$5.7 million in the year-ago quarter. Aurora and Canopy have yet to achieve profitability and are not even close yet.  Aphria has an upper hand in sales, with fiscal 2020 revenue coming in at $543.3 million Canadian dollars, a year-over-year increase of 129%.  Aphria's net revenue was up 18% from the year-ago quarter to CA$152 million, with CA$65.4 million coming from cannabis products and CA$99.1 million from distribution revenue. Irwin's strategy of focusing Aphria on its core operations in Canada has played out well.  Aphria was the first company to launch a variety of vape products in Canada which have generated great sales.  In contrast, Aurora and Canopy Growth's misteps proved unprofitable.  Aphria has already created a stronghold with its medical and recreational cannabis operations in Canada, with Germany, Italy, Malta, Colombia, and Argentina to follow.  Its cash position remains robust, with CA$497.2 million of cash and cash equivalents on the books in the recent quarter to fuel its expansion plans in Canada and internationally.